Advertisement
Advertisement
Trending on Dermatology Times
1
Depth, Speed, and Durability: What Matters Most in Modern Clinical Trials
2
Brepocitinib Demonstrates Superior Efficacy in Phase 2 BEACON Trial for Cutaneous Sarcoidosis
3
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
4
South Beach Symposium 2026: Gold's Top Pearls
5